Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study

By afschroeder • November 12, 2025

Wheeler DC, Pantalone KM, Guo L, Desai NR, Correa-Rotter R, Nicholas SB, Kim NH, Zheng Z, Scott C, Horvat-Broecker A, Merz M, Wanner C, Navaneethan SD. Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study. Clin Kidney J. 2025 Oct 6;18(11):sfaf305. doi: 10.1093/ckj/sfaf305. PMID: 41220896; PMCID: PMC12598660.

Tags: Chronic kidney disease, FINE-REAL, Finerenone, Nephrology, observational study, Publications, Type 2 diabetes

Research Code Sharing in Support of Gold Standard Science

Klonoff DC, Espinoza J, Mader JK, Heinemann L, Cobelli C, Kerr D, Kovatchev B, Najafi B, Prahalad P, Zheng Y, Shao MM, Scheideman AF, DuNova[...]

Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol

Naim MAAZ, Sumida K, Streja E, Thomas F, Davis RL, Kalantar-Zadeh K, Kovesdy CP. Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on[...]

Letter to the Editor re: Valenzuela et al. 2025 STAR working group report on dd-cfDNA validation

Bromberg JS, Bunnapradist S, Demko ZP, Gauthier P. Letter to the Editor re: Valenzuela et al. 2025 STAR working group report on dd-cfDNA validation. Am[...]